Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 310,810 | 174,046 | 254,844 | 465,293 | 680,112 |
| Marketable Securities | 854,201 | 989,052 | 1,280,833 | 1,244,453 | 1,180,484 |
| TOTAL | $1,205,740 | $1,213,097 | $1,588,226 | $1,769,176 | $1,946,332 |
| Non-Current Assets | |||||
| PPE Net | 66,063 | 92,477 | 96,018 | 99,309 | 104,126 |
| Investments And Advances | 279,992 | 359,724 | 105,275 | 39,617 | 52,358 |
| Intangibles | 35,836 | 39,402 | 39,502 | 42,394 | 42,527 |
| Other Non-Current Assets | 81,924 | 89,269 | 90,039 | 94,399 | 98,531 |
| TOTAL | $463,815 | $580,872 | $330,834 | $275,719 | $297,542 |
| Total Assets | $1,669,555 | $1,793,969 | $1,919,060 | $2,044,895 | $2,243,874 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,389 | 7,114 | 6,334 | 3,627 | 12,362 |
| Accrued Expenses | 75,321 | 72,260 | 104,220 | 146,111 | 197,580 |
| TOTAL | $96,412 | $94,068 | $175,407 | $165,050 | $225,623 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 16,702 | 14,694 | 64,853 | 15,312 | 15,681 |
| Other Non-Current Liabilities | 139,473 | 151,019 | 153,417 | 151,553 | 154,836 |
| TOTAL | $139,473 | $152,545 | $153,417 | $204,760 | $208,043 |
| Total Liabilities | $235,885 | $246,613 | $328,824 | $369,810 | $433,666 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 136,640 | 136,059 | 135,032 | 134,521 | 134,251 |
| Common Shares | 14 | 14 | 13 | 13 | 13 |
| Retained earnings | -441,478 | -303,100 | -237,824 | -121,851 | 41,562 |
| Other shareholders' equity | -2,879 | -2,397 | -815 | -1,900 | -2,903 |
| TOTAL | $1,433,670 | $1,547,356 | $1,590,236 | $1,675,085 | $1,810,208 |
| Total Liabilities And Equity | $1,669,555 | $1,793,969 | $1,919,060 | $2,044,895 | $2,243,874 |